Old Mission Capital’s Bristol-Myers Squibb BMY Stock Holding History

Old Mission Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,927	Closed	-$214K	–	1480
2022 Q1	$214K	Buy	+2,927	New	+$197K	0.01%	1027
2020 Q4	–	Sell	-3,874	Closed	-$234K	–	532
2020 Q3	$234K	Buy	+3,874	New	+$233K	0.02%	377
2018 Q3	–	Sell	-5,409	Closed	-$299K	–	254
2018 Q2	$299K	Buy	+5,409	New	+$292K	0.03%	184

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Old Mission Capital's BMY Position: Q2 2022 in Review

Old Mission Capital sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 2,927 shares — an estimated $214K sold.

Old Mission Capital first reported a position in BMY in Q2 2018 and held it in 3 quarters. The position peaked at $299K in Q2 2018. 2,537 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

Old Mission Capital reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
Old Mission Capital sold 2,927 Bristol-Myers Squibb shares in Q2 2022, an estimated $214K.
Old Mission Capital first reported a position in Bristol-Myers Squibb in Q2 2018 and held it in 3 quarters.
Old Mission Capital's Bristol-Myers Squibb position peaked at $299K in Q2 2018.
2,537 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on Old Mission Capital's 13F filing for Q2 2022, filed 5 Aug 2022.